NovaBay Pharmaceuticals (NBY) Stock Price & Financial Analysis
NovaBay Pharmaceuticals Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About NovaBay Pharmaceuticals
What is the current stock price for NBY?
As of the latest trading session, NBY stock trades at $1.59. The 52-week range is $0.54–$99.75, with a day range of $1.58–$1.72.
What is the P/E ratio for NBY?
The P/E ratio (Price-to-Earnings) for NBY is shown in the Key Statistics section. This valuation metric helps compare NovaBay Pharmaceuticals, Inc. to industry peers.
Does NBY pay dividends?
Yes, NovaBay Pharmaceuticals pays a 251.57% annual dividend yield ($4.00 per share). The payout ratio is 724.8%. The last ex-dividend date was 2026-09-29.
What do analysts recommend for NBY?
Analyst ratings and recommendations for NBY are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of NBY?
NovaBay Pharmaceuticals's market capitalization is $9.3M, classifying it as a micro-cap company. NovaBay Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.